NEXIUM Capsule Specific Clinical Experience Investigation (S-CEI) to Investigate Treatment Response to NEXIUM in Patients With Reflux Esophagitis (RE) - Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Esomeprazole (Primary)
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 21 Mar 2017 Status changed from active, no longer recruiting to completed.
- 15 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 20 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.